The Subject Expert Committee (SEC) on COVID-19 at the CDSCO, which
held its meeting on Monday, deliberated on the application and asked
the firm to submit a revised protocol stating it will have to conduct
combined phase 2 and 3 clinical trials, the sources told PTI.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/dr-reddys-asked-to-reapply-for-phase-2-3-clinical-trials-of-russian-covid-19-vaccine/articleshow/78507523.cms
No comments:
Post a Comment